tm logo
Trademark Search
BIAL Design

View On IC.GC.CA

BIAL Design
REGISTERED

on 28 Jan 2009

Last Applicant/ Owned by

Bial-Portela & Ca., S.A.

À Av. Siderurgia Nacional4785-457 São MamedeDo Coronado

PT

Serial Number

1219816 filed on 09th Jun 2004

Registration Number

TMA733424 registered on 28th Jan 2009

Registration expiry Date

28th Jan 2034

Correspondent Address

1, Place Ville MarieSuite 2500, Montreal

QUEBEC

CA

H3B1R1

BIAL Design

Trademark usage description

pharmaceutical preparations for the treatment of cardiovascular disease, urological disorders, gastrointestinal disorders, allergies, diabetes, hypert Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of cardiovascular disease, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, fungal disorders; pharmaceutical preparations, namely anti-inflammatory analgesics; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations; pharmaceutical preparations namely decongestants and anti-histamines; pharmaceutical preparations for the treatment of pains, cough, fever, angina, otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; anaesthetics, analgesics, frostbite salve for pharmaceutical purposes, haemorrhoid preparations, pharmaceutical preparations for the treatment of headaches, medicines for alleviating constipation, contraceptive chemicals, radiological contrast substances for medical purposes, diagnostic preparations for medical purposes, drugs for the treatment of pain, fever, angina, otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; pharmaceutical preparations for the treatment of diabetes, cancer; pharmaceutical preparations for the prevention and/or treatment of cancer, carcinomas and sarcomas; pharmaceutical preparations for the prevention and/or treatment of tumours of any description; pharmaceutical preparations, namely platelet stimulating factors; pharmaceutical preparations for the treatment of the central nervous system, namely encephalitis, epilepsy, bipolar disorder, neuropathic pain, migraine, generalized anxiety disorder, social phobia, diabetic neuropathies, panic disorder, postoperative pain, back pain, fibromyalgia, and postherpetic neuralgia, post-traumatic stress disorder, Parkinson’s disease, Alzheimers; pharmaceutical preparations for the treatment of psychiatric diseases, namely schizophrenia, anxiety disorders, mood disorders, cognitive disorders, depression, mania; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, pharmaceutical preparations for treatment of gout, namely broncho-dilators and anti-asthmatic preparations, peripheral nervous system, cardiovascular system, gastro-intestinal system; prescription pharmaceutical preparations and substances for use in pain control, anaesthesia, oncology, prescription pharmaceutical preparations and substances for the treatment and prevention of diabetes; pharmaceutical preparations and substances, namely anti-infectives, anti-bacterials, antibiotics, antivirals, antidiabetic preparations, nondepolarizing skeletal neuromuscular blocking agents, hemostatic agents, expectorants, anti-leukemia agents, anti-arrhythmia, dermatologicals and vasopressors, pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity, and respiratory and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI), cerebral vasodilators; pharmaceutical preparations for the treatment of smooth muscle disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments or bone, tremors, namely, spasmodic smooth, striated or cardiac muscles; and pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; muscle dystonias, nerve disorders, spasmodic striated, smooth or cardiac muscles; pharmaceutical preparations for the treatment of cerebral palsy; pharmaceutical preparations namely muscle relaxants and anti-emetics, xantine oxidase inhibitors; pharmaceutical preparations namely scabecides, anti-malarials

Classification kind code

12

Class [042]
Pharmaceutical, medical and biological research and development in the field of human therapeutics; conducting of pre-clinical and clinical test research in the pharmaceutical and medical fields; scientific research and development in the field of human medicine.

Classification kind code

12

Mark Details

Serial Number

1219816

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 67
on 31st May 2005		Agent Name Changed
Submitted for opposition 68
on 31st May 2005		Rep for Service Name Changed
Submitted for opposition 67
on 25th May 2005		Agent Name Changed
Submitted for opposition 68
on 25th May 2005		Rep for Service Name Changed
Submitted for opposition 12
on 11th Feb 2005		Extension of Time
Submitted for opposition 22
on 05th Oct 2004		Search Recorded
Submitted for opposition 20
on 05th Oct 2004		Examiner's First Report
Submitted for opposition 1
on 10th Jun 2004		Created
Submitted for opposition 31
on 10th Jun 2004		Formalized
Submitted for opposition 30
on 09th Jun 2004		Filed